Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.55)
# 271
Out of 5,102 analysts
586
Total ratings
52.23%
Success rate
25.33%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $13.07 | +53.02% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $1.46 | +242.47% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $488.49 | +2.36% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $172.50 | +12.46% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $12.80 | -6.25% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $16.90 | +59.76% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $6.47 | +255.49% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $87.81 | -31.67% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $26.68 | +19.94% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $445.93 | +23.34% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $195.24 | -38.54% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $5.74 | +39.37% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $6.94 | -71.18% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $32.59 | +7.39% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $10.33 | +35.53% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $33.09 | +5.77% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $5.04 | +177.78% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $67.44 | +11.21% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $71.60 | -5.03% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $19.42 | +95.67% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $21.69 | +15.26% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $17.37 | +84.23% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.58 | +295.78% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $19.43 | -17.63% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $12.57 | +90.93% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $3.22 | +272.67% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $96.78 | -60.74% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.19 | +265.30% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $154.75 | +8.56% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.96 | +461.22% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.45 | +589.66% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $16.75 | +31.34% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $9.81 | +103.87% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.36 | +408.47% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.48 | +190.18% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.02 | +56.70% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $6.01 | +282.70% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.07 | +1,301.87% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $96.63 | -12.04% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $22.94 | +52.57% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $9.68 | +674.79% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $41.61 | +80.25% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.54 | +175.59% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.96 | +152.53% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.79 | +18,817.90% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $14.47 | +314.65% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.59 | +226.80% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.95 | +4,132.80% | 3 | Mar 16, 2022 |
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $13.07
Upside: +53.02%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.46
Upside: +242.47%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $488.49
Upside: +2.36%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $172.50
Upside: +12.46%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $12.80
Upside: -6.25%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $16.90
Upside: +59.76%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $6.47
Upside: +255.49%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $87.81
Upside: -31.67%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $26.68
Upside: +19.94%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $445.93
Upside: +23.34%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $195.24
Upside: -38.54%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $5.74
Upside: +39.37%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $6.94
Upside: -71.18%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $32.59
Upside: +7.39%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $10.33
Upside: +35.53%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $33.09
Upside: +5.77%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.04
Upside: +177.78%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $67.44
Upside: +11.21%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $71.60
Upside: -5.03%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $19.42
Upside: +95.67%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $21.69
Upside: +15.26%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $17.37
Upside: +84.23%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $7.58
Upside: +295.78%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $19.43
Upside: -17.63%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $12.57
Upside: +90.93%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $3.22
Upside: +272.67%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $96.78
Upside: -60.74%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.19
Upside: +265.30%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $154.75
Upside: +8.56%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.96
Upside: +461.22%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.45
Upside: +589.66%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $16.75
Upside: +31.34%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $9.81
Upside: +103.87%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.36
Upside: +408.47%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.48
Upside: +190.18%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.02
Upside: +56.70%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $6.01
Upside: +282.70%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.07
Upside: +1,301.87%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $96.63
Upside: -12.04%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $22.94
Upside: +52.57%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $9.68
Upside: +674.79%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $41.61
Upside: +80.25%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.54
Upside: +175.59%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $3.96
Upside: +152.53%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.79
Upside: +18,817.90%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $14.47
Upside: +314.65%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.59
Upside: +226.80%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.95
Upside: +4,132.80%